These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 34358324

  • 1. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
    Kushida CA, Shapiro CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, Rosenberg R, Roy A, Seiden D, Dubow J, Dauvilliers Y.
    Sleep; 2022 Jun 13; 45(6):. PubMed ID: 34358324
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial.
    Dauvilliers Y, Roth T, Bogan R, Thorpy MJ, Morse AM, Roy A, Dubow J, Gudeman J.
    Sleep; 2023 Nov 08; 46(11):. PubMed ID: 37246913
    [Abstract] [Full Text] [Related]

  • 3. Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.
    Roth T, Dauvilliers Y, Thorpy MJ, Kushida C, Corser BC, Bogan R, Rosenberg R, Dubow J, Seiden D.
    CNS Drugs; 2022 Apr 08; 36(4):377-387. PubMed ID: 35380374
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
    Lecendreux M, Plazzi G, Dauvilliers Y, Rosen CL, Ruoff C, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    J Clin Sleep Med; 2022 Sep 01; 18(9):2217-2227. PubMed ID: 35689598
    [Abstract] [Full Text] [Related]

  • 5. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J, Swick T, Bogan R, Lai C, Carter LP.
    Sleep Med; 2016 Aug 01; 24():57-62. PubMed ID: 27810187
    [Abstract] [Full Text] [Related]

  • 6. Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.
    Roth T, Thorpy MJ, Kushida CA, Horsnell M, Gudeman J.
    J Comp Eff Res; 2023 Dec 01; 12(12):e230133. PubMed ID: 37971303
    [Abstract] [Full Text] [Related]

  • 7. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
    Bogan RK, Foldvary-Schaefer N, Skowronski R, Chen A, Thorpy MJ.
    CNS Drugs; 2023 Apr 01; 37(4):323-335. PubMed ID: 36947322
    [Abstract] [Full Text] [Related]

  • 8. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
    Dauvilliers Y, Šonka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ.
    CNS Drugs; 2022 Jun 01; 36(6):633-647. PubMed ID: 35635687
    [Abstract] [Full Text] [Related]

  • 9. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis.
    Alshaikh MK, Tricco AC, Tashkandi M, Mamdani M, Straus SE, BaHammam AS.
    J Clin Sleep Med; 2012 Aug 15; 8(4):451-8. PubMed ID: 22893778
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy.
    Bogan RK, Thorpy MJ, Dauvilliers Y, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Tang L, Skobieranda F, Šonka K.
    Sleep; 2021 Mar 12; 44(3):. PubMed ID: 33184650
    [Abstract] [Full Text] [Related]

  • 11. Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
    Rosenberg R, Braceras R, Macfadden W, Candler S, Black J, Ruoff C.
    Neurol Ther; 2023 Dec 12; 12(6):1805-1820. PubMed ID: 37755650
    [Abstract] [Full Text] [Related]

  • 12. Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers.
    Bogan R, Thorpy MJ, Winkelman JW, Dubow J, Gudeman J, Seiden D.
    Sleep Med; 2022 Dec 12; 100():442-447. PubMed ID: 36252412
    [Abstract] [Full Text] [Related]

  • 13. Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy.
    Husain AM, Bujanover S, Ryan R, Scheckner B, Black J, Profant J.
    J Clin Sleep Med; 2020 Sep 15; 16(9):1469-1474. PubMed ID: 32356515
    [Abstract] [Full Text] [Related]

  • 14. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
    Bogan RK, Roth T, Schwartz J, Miloslavsky M.
    J Clin Sleep Med; 2015 Apr 15; 11(4):427-32. PubMed ID: 25580605
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 16. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G, Ruoff C, Lecendreux M, Dauvilliers Y, Rosen CL, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    Lancet Child Adolesc Health; 2018 Jul 01; 2(7):483-494. PubMed ID: 30169321
    [Abstract] [Full Text] [Related]

  • 17. Criteria for gauging response to sodium oxybate for narcolepsy.
    Steffen AD, Lai C, Weaver TE.
    J Sleep Res; 2018 Aug 01; 27(4):e12628. PubMed ID: 29205601
    [Abstract] [Full Text] [Related]

  • 18. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul 01; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group.
    J Clin Sleep Med; 2005 Oct 15; 1(4):391-7. PubMed ID: 17564408
    [Abstract] [Full Text] [Related]

  • 20. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    J Clin Sleep Med; 2010 Dec 15; 6(6):596-602. PubMed ID: 21206549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.